Skip to Main Content

Advertisement

Skip Nav Destination

Abstract 1552: A novel PD1-IL2v immunocytokine for preferential cis-activation of IL-2R signaling on PD-1 expressing T cell subsets strongly potentiates anti-tumor T cell activity of PD-1 checkpoint inhibition and IL-2R-beta-gamma agonism

Cancer Res (2019) 79 (13_Supplement): 1552.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Ana Victoria Casadesús
  • Beatriz María Cruz
  • Wilden Díaz
  • Miguel Ángel González
  • Tania Gómez
  • Briandy Fernández
  • Addys González
  • Nuris Ledón
  • Katya Sosa
  • Kathleen Castro
  • Armando López
  • Claudia Plasencia
  • Yaima Ramírez
  • Jean-Luc Teillaud
  • Calixto Hernández
  • Kalet León
  • Tays Hernández
Frontiers in Immunology (2022) 13
  • Erin Runbeck
  • Silvia Crescioli
  • Sophia N. Karagiannis
  • Sophie Papa
Antibodies (2021) 10 (1): 10.
  • Biaggio Uricoli
  • Lacey A. Birnbaum
  • Priscilla Do
  • James M. Kelvin
  • Juhi Jain
  • Emma Costanza
  • Andrew Chyong
  • Christopher C. Porter
  • Sarwish Rafiq
  • Erik C. Dreaden
Advanced Healthcare Materials (2021) 10 (15)
  • Willem W. Overwijk
  • Mary A. Tagliaferri
  • Jonathan Zalevsky
Annual Review of Medicine (2021) 72 (1): 281.
Close Modal

or Create an Account

Close Modal
Close Modal